Shire v EMA: European General Court provides clarification for designation of orphan medicinal products

Published date30 May 2018
Law FirmArnold & Porter Kaye Scholer LLP
AuthorFenella Fletcher-Flood and Ian Dodds-Smith
Subject MatterHealth Care

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT